Organization · Venture Capital
Delin Ventures
Delin Ventures is a London-based venture capital firm focused on early-stage investments in technology and life sciences. It operates two main funds targeting pre-seed and seed-stage companies, particularly in cell therapy and tech-enabled models.
Overview
What Delin Ventures does
What Delin Ventures is
Delin Ventures is a London-based venture capital firm focused on early-stage investments in technology and life sciences. It operates two main funds targeting pre-seed and seed-stage companies, particularly in cell therapy and tech-enabled models.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Delin Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Delin Ventures as a funder
Investment thesis
Delin Ventures focuses on supporting entrepreneurs and scientists in life sciences and technology, with a mission to make cell therapies scalable and accessible while backing tech-enabled operator models in Germany, Austria, and Switzerland.
Focus narrative
Delin Ventures operates two main funds: the Life Sciences Fund, focusing on cell therapy companies from pre-seed onwards, and the Technology Fund, which invests in pre-seed and seed rounds of tech-enabled startups primarily in Germany, Austria, and Switzerland. The firm emphasizes scalable and commercially viable solutions in therapeutics, services, and manufacturing technologies.
Value beyond capital
Delin Ventures provides significant value to its portfolio companies through strategic support in fundraising, storytelling, and access to capital, customers, and talent. The firm leverages its expertise in life sciences and technology to help startups scale effectively and navigate the complexities of their respective markets.
Terms and economics
- Typical check
- $500,000–$2,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Swarm Oncology: Personalized T cell therapies for treating solid tumors. Oribiotech: Manufacturing platform to streamline and scale cell therapy production. Adthera: Digital-first contract development and manufacturing organization for cell and gene therapies. Umed: Accelerates drug development and clinical research through real-world evidence collection. Immvention Therapeutics: Develops first-in-class Bach1 inhibitors for sickle cell disease. Turbine: AI-driven simulated cell platform for in-silico experiments. Tilikum Therapeutics: Develops inhibitors of PARP-1 for cancer treatment.
Common questions
What to know about Delin Ventures
Upseed classifies Delin Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.